🔗 Share this article

A shadow market for unlicensed weight-loss drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Investigational Treatment Gaining Traction Online

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Viewers are encouraged to contact these profiles privately for source information, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with numerous of members share comparison images, administration instructions and claims of next-day British shipping. Sellers promote the drug there before directing customers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Experts Voice Worries

However, doctors and pharmacists have warned that the sale of what remains an unapproved drug in the UK is a cause for concern and could lead to individuals administering products of uncertain source.

Several experts said the popularity for retatrutide could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for human use under the British medical regulations.

Some influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate medicines, advertising, and customer regulations, risking fines, legal action or prison.

Platform Response and Content Elimination

Based on the social media company, the platform has removed violative content and banned related keywords and search suggestions. The company said it was committed to maintaining the service secure and allocating resources in strengthening enforcement strategies.

Digital Marketplace Activities

Research also found groups with up to 9,000 members marketing retatrutide using the platform's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of users, populated with photos of slimming results, glowing testimonials and detailed guides for mixing or administering at residence.

After moments of joining one community, a seller shared contact information, where most purchases occur. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about weight, medical conditions or previous experience.

Product Information and Pricing

Inside these groups, messages show black plastic parcels with postal service stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When questioned how much time a pen should be used, vendors give contradictory answers varying between a several days to “depends on your body”.

Service Oversight and Safety Actions

A representative for the messaging service stated it actively monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting materials they can’t verify. Even if the research behind this drug is valid, these digital products may not include what they claim,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the surge in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.

Her team has already seen individuals harmed by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly experimental substance not yet approved … may expose users to potentially significant health risks”.